GSK3B and nasopharyngeal carcinoma: A study has shown that BMI1 inhibited the expression of PTEN, and modulated PI3K/AKT/GSK-3b/snail signaling, which promotes EMT and enhances the metastatic ability of nasopharyngeal cancer cells [25].